Mary Marcaida - 94080 South San Francisco, CA

Business Name: Mary Marcaida
Categorized In: Research and Development Laboratories
Address: 834 Miller Avenue, South San Francisco, CA 94080
Phone Number: (415) 503-7415
Contact Person: Mary Marcaida
NAICS Code: 541712
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 2009
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $0 to $49.999
Share This Business:
Similar Businesses: Hana Biosciences Inc - South San Francisco, CA 94080
Cristian Ionescu-Zanetti - South San Francisco, CA 94080
Mlcb Molecular Cloning Lab - South San Francisco, CA 94080
Predicant Biosciences Inc - South San Francisco, CA 94080
Biospect Inc - South San Francisco, CA 94080
Cureline Biopathology LLC - South San Francisco, CA 94080
Brains On-Line Us - South San Francisco, CA 94080
Janssen Alzheimer Immunothrpy - South San Francisco, CA 94080
Biovis Abilicy - South San Francisco, CA 94080
Giad Technology Inc - South San Francisco, CA 94080
Biometric Research Institut E - South San Francisco, CA 94080
Ease Laboratories - South San Francisco, CA 94080
Nanosystems LLC - South San Francisco, CA 94080
Compare Networks Inc - South San Francisco, CA 94080
Genentech, Inc - South San Francisco, CA 94080
R Hk Inc - South San Francisco, CA 94080

Mary Marcaida provides professional Research and Development Laboratories from its single location at the coordinates 37.660335,-122.428047.

The company offers B2B variables under the SIC code 8731 and NAICS code 541712, while making an annual revenue of $0 to $49.999 and hiring a total of 1 to 4 employees.

Founded in 2009, the company can now be visited at 834 Miller Avenue, South San Francisco, California 94080 or contacted through representative Mary Marcaida at (415) 503-7415.

For frequently asked questions and further inquiries about professional Research and Development Laboratories, get to know more about Mary Marcaida through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.